Sagimet Biosciences Inc Series A (SGMT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SGMT | CRDF | CCCC | ||
| Company | Sagimet Biosciences Inc Series A | Cardiff Oncology Inc | C4 Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 5.81 | 2.85 | 1.9600 | ||
| High | 6.02 | 2.91 | 1.9600 | ||
| Low | 5.80 | 2.79 | 1.9000 | ||
| Latest | 5.92 | 2.81 | 1.9100 | ||
| Change | +0.07 | -0.06 | -0.0500 | ||
| % Change | +1.20% | -2.09% | -2.55% | ||
| Volume | 265,800 | 692,000 | 920,000 | ||
| 20-Day Average Volume | 582,490 | 1,106,790 | 1,948,375 | ||
| Previous Close | 5.85 | 2.87 | 1.9600 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 6.15 | 2.58 | 2.2890 | ||
| 20-Day Raw Stochastic | 13.31% | 61.09% | 1.06% | ||
| 20-Day Relative Strength | 40.81 | 59.70 | 37.89 | ||
| Weighted Alpha | -20.25 | -15.91 | -54.15 | ||
| Today's Opinion | 72% Sell | 40% Buy | 40% Sell | ||
| Previous Opinion | 72% Sell | 40% Buy | 40% Sell | ||
| Last Month's Opinion | 16% Sell | 88% Sell | 88% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.50% since 12/23/25 | -3.44% since 12/23/25 | -5.45% since 12/23/25 | ||
| Low | 5.80 on 12/31/25 | 2.79 on 12/31/25 | 1.9000 on 12/31/25 | ||
| High | 6.12 on 12/24/25 | 3.31 on 12/26/25 | 2.1350 on 12/29/25 | ||
| 1-Month | |||||
| %Chg | -18.01% since 11/28/25 | +23.25% since 11/28/25 | -29.52% since 11/28/25 | ||
| Low | 5.76 on 12/15/25 | 2.03 on 12/03/25 | 1.9000 on 12/31/25 | ||
| High | 7.05 on 12/01/25 | 3.31 on 12/26/25 | 2.8400 on 12/03/25 | ||
| 3-Month | |||||
| %Chg | -13.70% since 09/30/25 | +36.41% since 09/30/25 | -13.96% since 09/30/25 | ||
| Low | 5.76 on 12/15/25 | 1.90 on 11/21/25 | 1.9000 on 12/31/25 | ||
| High | 9.46 on 10/27/25 | 3.31 on 12/26/25 | 2.8400 on 12/03/25 | ||
| 6-Month | |||||
| %Chg | -22.31% since 06/30/25 | -10.79% since 06/30/25 | +33.57% since 06/30/25 | ||
| Low | 5.76 on 12/15/25 | 1.90 on 11/21/25 | 1.3950 on 07/01/25 | ||
| High | 11.41 on 07/25/25 | 4.55 on 07/18/25 | 3.6500 on 09/15/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 190,254 | 193,326 | 189,951 | ||
| Shares Outstanding, K | 32,522 | 67,361 | 96,914 | ||
| Annual Sales | 0 | 680,000 | 35,580,000 | ||
| Annual Net Income | -45,570,000 | -45,430,000 | -105,320,000 | ||
| Last Quarter Sales | 0 | 120,000 | 11,230,000 | ||
| Last Quarter Net Income | -12,910,000 | -11,260,000 | -32,170,000 | ||
| 60-Month Beta | 3.32 | 1.35 | 2.87 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.40 on 11/13/25 | -0.17 on 11/06/25 | -0.44 on 11/06/25 | ||
| Latest Earnings Date | 03/11/26 | 02/26/26 | 02/26/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||